Biomerica set to release earnings this Friday – here’s what you need to know.

Biomerica (NASDAQ:BMRA) is set to release Q2 earnings this Friday, with experts forecasting an expected EPS of -$0.05. This would mark a 37% improvement for Q2 Earnings Year on Year. The medical diagnostic manufacturer has thrived on the opportunity this year to develop a viable COVID-19 test. Biomerica’s rapid COVID-19 test is marketed produce results […]

Biomerica surges 781% over 3 days – is this the most promising stock during the COVID-19 outbreak

Biomerica Inc. (NASDAQ:BMRA) has been in the spotlight in recent weeks as news broke that the company is currently shipping samples of it’s Coronavirus test out of the US. As of now, there is no efficient way of testing the virus without it being examined in a lab – generally taking a few days to process. […]